000			01486 a2200457 4500
005			20250513233750.0
264		0	_c20010628
008			200106s 0 0 eng d
022			_a0929-1903
024	7		_a10.1038/sj.cgt.7700283 _2doi
040			_aNLM _beng _cNLM
100	1		_aHeise, C P
245	0	0	_aB7.1 expression eliminates tumor resistance to IL-12 gene therapy. _h[electronic resource]
260			_bCancer gene therapy _cFeb 2001
300			_a118-27 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAbatacept
650	0	4	_aAnimals
650	0	4	_aAntigens, CD
650	0	4	_aAntigens, Differentiation _xmetabolism
650	0	4	_aB7-1 Antigen _xmetabolism
650	0	4	_aCD28 Antigens _xmetabolism
650	0	4	_aCD8-Positive T-Lymphocytes _xmetabolism
650	0	4	_aCTLA-4 Antigen
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aGenetic Therapy
650	0	4	_aImmunoconjugates
650	0	4	_aInterleukin-12 _xgenetics
650	0	4	_aKiller Cells, Natural _xmetabolism
650	0	4	_aMelanoma, Experimental _xmetabolism
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aSpleen _xpathology
650	0	4	_aTransfection
700	1		_aShi, F
700	1		_aAlbertini, M R
700	1		_aMahvi, D M
773	0		_tCancer gene therapy _gvol. 8 _gno. 2 _gp. 118-27
856	4	0	_uhttps://doi.org/10.1038/sj.cgt.7700283 _zAvailable from publisher's website
999			_c11199867 _d11199867